nodes	percent_of_prediction	percent_of_DWPC	metapath
Minoxidil—ABCC9—ABC-family proteins mediated transport—ABCB6—polycystic ovary syndrome	0.155	0.224	CbGpPWpGaD
Minoxidil—ABCC9—adipose tissue—polycystic ovary syndrome	0.0611	0.199	CbGeAlD
Minoxidil—KCNJ11—Type II diabetes mellitus—INS-IGF2—polycystic ovary syndrome	0.0549	0.0793	CbGpPWpGaD
Minoxidil—ABCC9—adrenal gland—polycystic ovary syndrome	0.0548	0.178	CbGeAlD
Minoxidil—ABCC9—female gonad—polycystic ovary syndrome	0.0511	0.166	CbGeAlD
Minoxidil—KCNJ11—Type II diabetes mellitus—INSR—polycystic ovary syndrome	0.0278	0.0401	CbGpPWpGaD
Minoxidil—KCNJ11—adrenal gland—polycystic ovary syndrome	0.0237	0.077	CbGeAlD
Minoxidil—KCNJ11—Type II diabetes mellitus—ADIPOQ—polycystic ovary syndrome	0.0232	0.0334	CbGpPWpGaD
Minoxidil—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.023	0.0332	CbGpPWpGaD
Minoxidil—KCNJ11—female gonad—polycystic ovary syndrome	0.0221	0.0718	CbGeAlD
Minoxidil—KCNJ11—Type II diabetes mellitus—SLC2A4—polycystic ovary syndrome	0.0219	0.0316	CbGpPWpGaD
Minoxidil—KCNJ11—endocrine gland—polycystic ovary syndrome	0.0205	0.0668	CbGeAlD
Minoxidil—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.0196	0.0283	CbGpPWpGaD
Minoxidil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—IGFBP1—polycystic ovary syndrome	0.0186	0.0268	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0162	0.0234	CbGpPWpGaD
Minoxidil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—polycystic ovary syndrome	0.0148	0.0213	CbGpPWpGaD
Minoxidil—KCNJ11—Type II diabetes mellitus—IRS1—polycystic ovary syndrome	0.0128	0.0185	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.0116	0.0167	CbGpPWpGaD
Minoxidil—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.0113	0.0163	CbGpPWpGaD
Minoxidil—PTGS1—endometrium—polycystic ovary syndrome	0.011	0.0358	CbGeAlD
Minoxidil—ABCC9—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.0105	0.0151	CbGpPWpGaD
Minoxidil—PTGS1—uterus—polycystic ovary syndrome	0.0101	0.033	CbGeAlD
Minoxidil—PTGS1—pituitary gland—polycystic ovary syndrome	0.00997	0.0324	CbGeAlD
Minoxidil—PTGS1—adipose tissue—polycystic ovary syndrome	0.00993	0.0323	CbGeAlD
Minoxidil—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00992	0.0143	CbGpPWpGaD
Minoxidil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—polycystic ovary syndrome	0.00929	0.0134	CbGpPWpGaD
Minoxidil—PTGS1—adrenal gland—polycystic ovary syndrome	0.0089	0.0289	CbGeAlD
Minoxidil—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00855	0.0124	CbGpPWpGaD
Minoxidil—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00843	0.0122	CbGpPWpGaD
Minoxidil—ABCC9—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00833	0.012	CbGpPWpGaD
Minoxidil—PTGS1—female gonad—polycystic ovary syndrome	0.0083	0.027	CbGeAlD
Minoxidil—PTGS1—vagina—polycystic ovary syndrome	0.00825	0.0268	CbGeAlD
Minoxidil—PTGS1—endocrine gland—polycystic ovary syndrome	0.00772	0.0251	CbGeAlD
Minoxidil—ABCC9—Neuronal System—DLG4—polycystic ovary syndrome	0.00736	0.0106	CbGpPWpGaD
Minoxidil—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00708	0.0102	CbGpPWpGaD
Minoxidil—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—polycystic ovary syndrome	0.00706	0.0102	CbGpPWpGaD
Minoxidil—KCNJ1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00698	0.0101	CbGpPWpGaD
Minoxidil—KCNJ11—Regulation of insulin secretion—GNAS—polycystic ovary syndrome	0.00673	0.00973	CbGpPWpGaD
Minoxidil—KCNJ1—Neuronal System—DLG4—polycystic ovary syndrome	0.00617	0.00891	CbGpPWpGaD
Minoxidil—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00604	0.00872	CbGpPWpGaD
Minoxidil—KCNJ11—Integration of energy metabolism—GNAS—polycystic ovary syndrome	0.0053	0.00765	CbGpPWpGaD
Minoxidil—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00526	0.00759	CbGpPWpGaD
Minoxidil—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00489	0.00706	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00474	0.00685	CbGpPWpGaD
Minoxidil—KCNJ11—Regulation of insulin secretion—INS—polycystic ovary syndrome	0.00451	0.00651	CbGpPWpGaD
Minoxidil—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00445	0.00642	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00436	0.0063	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00408	0.0059	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00406	0.00586	CbGpPWpGaD
Minoxidil—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00387	0.00558	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00371	0.00536	CbGpPWpGaD
Minoxidil—KCNJ11—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00355	0.00512	CbGpPWpGaD
Minoxidil—KCNJ11—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00346	0.00499	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00315	0.00455	CbGpPWpGaD
Minoxidil—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00313	0.00451	CbGpPWpGaD
Minoxidil—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00312	0.0045	CbGpPWpGaD
Minoxidil—ABCC9—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00311	0.0045	CbGpPWpGaD
Minoxidil—KCNJ11—Neuronal System—DLG4—polycystic ovary syndrome	0.00306	0.00442	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00299	0.00432	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—NMNAT3—polycystic ovary syndrome	0.00281	0.00406	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00279	0.00403	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00264	0.00381	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.0026	0.00375	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—LPCAT2—polycystic ovary syndrome	0.00257	0.00372	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—SUOX—polycystic ovary syndrome	0.00257	0.00372	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00251	0.00362	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—ISYNA1—polycystic ovary syndrome	0.00239	0.00345	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00236	0.00341	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00236	0.00341	CbGpPWpGaD
Minoxidil—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00232	0.00336	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.0021	0.00303	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.00205	0.00297	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—TEAD2—polycystic ovary syndrome	0.00203	0.00294	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—AKR1C2—polycystic ovary syndrome	0.00203	0.00294	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00198	0.00286	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00193	0.00278	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00188	0.00271	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00179	0.00259	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—PNPLA2—polycystic ovary syndrome	0.0017	0.00246	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00166	0.00239	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—SRD5A1—polycystic ovary syndrome	0.00162	0.00233	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—STAR—polycystic ovary syndrome	0.00154	0.00223	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00152	0.0022	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.00146	0.0021	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00139	0.00201	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—HMMR—polycystic ovary syndrome	0.00137	0.00198	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00136	0.00196	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.00133	0.00192	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.00133	0.00192	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00131	0.0019	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—HSD3B1—polycystic ovary syndrome	0.00131	0.00189	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00124	0.00179	CbGpPWpGaD
Minoxidil—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.00123	0.00178	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00121	0.00175	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—LHB—polycystic ovary syndrome	0.00119	0.00173	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—HSD3B2—polycystic ovary syndrome	0.00117	0.00169	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—AKR1C1—polycystic ovary syndrome	0.00113	0.00163	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00113	0.00163	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00107	0.00155	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.00105	0.00152	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.00105	0.00152	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—SULT2A1—polycystic ovary syndrome	0.00104	0.0015	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00101	0.00146	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—RRM2—polycystic ovary syndrome	0.00101	0.00146	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000997	0.00144	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—YAP1—polycystic ovary syndrome	0.000972	0.0014	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—NAMPT—polycystic ovary syndrome	0.000934	0.00135	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—CYP11A1—polycystic ovary syndrome	0.000922	0.00133	CbGpPWpGaD
Minoxidil—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000917	0.00132	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000882	0.00127	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—AKR1C3—polycystic ovary syndrome	0.000871	0.00126	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—CYP17A1—polycystic ovary syndrome	0.000857	0.00124	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000836	0.00121	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000798	0.00115	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000789	0.00114	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—TH—polycystic ovary syndrome	0.000742	0.00107	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—SLC2A4—polycystic ovary syndrome	0.000722	0.00104	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000711	0.00103	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—CYP19A1—polycystic ovary syndrome	0.000678	0.00098	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000678	0.00098	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000671	0.000968	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000636	0.000918	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000619	0.000893	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—GNAS—polycystic ovary syndrome	0.000606	0.000875	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000605	0.000873	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000586	0.000846	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	0.000577	0.000833	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	0.000547	0.00079	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000539	0.000778	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000522	0.000754	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	0.00051	0.000736	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.000503	0.000727	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000483	0.000698	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000481	0.000694	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000477	0.000689	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000474	0.000685	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000451	0.000651	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000444	0.000641	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	0.000413	0.000597	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	0.000408	0.000589	CbGpPWpGaD
Minoxidil—KCNJ11—Metabolism—INS—polycystic ovary syndrome	0.000405	0.000586	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000384	0.000555	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000374	0.00054	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000351	0.000507	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000313	0.000453	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000299	0.000431	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000283	0.000409	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000264	0.000381	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	0.000214	0.000309	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—POMC—polycystic ovary syndrome	0.000211	0.000305	CbGpPWpGaD
Minoxidil—PTGS1—Metabolism—INS—polycystic ovary syndrome	0.00021	0.000303	CbGpPWpGaD
